Marker Therapeutics, Inc. (MRKR) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Marker Therapeutics, Inc. (MRKR) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

MRKR Cash Flow Statement

Marker Therapeutics, Inc. (MRKR) cash flow statement — 27-year operating, investing & financing cash flows

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Cash from Operations	-3.72M	-1.4M	-1.9M	-2.74M	-1.88M	-5.5M	-4.7M	1.2M	-3.57M	-3.84M	-2.37M	-1.13M	-7.06M	-5.89M	-6.31M	-7.65M	-794.71K	-12.23M	-4.86M	-6.52M
Operating CF Margin %	-	-	-	-221.9%	-218.11%	-1575.39%	-208.86%	62.18%	-305.12%	-308.43%	-224.09%	-437.67%	-925.27%	-477.04%	-830.6%	-764.92%	-100.53%	-1267.84%	-391.24%	-
Operating CF Growth %	-97.85%	74.47%	59.6%	-328.47%	47.35%	-43.33%	-98.65%	206.21%	49.44%	34.83%	62.45%	85.25%	-787.95%	51.84%	-29.79%	-17.35%	88.5%	-35.91%	21.88%	-53.69%
Net Income	-1.83M	-3.18M	-1.7M	-2M	-4.02M	-4.45M	-3.84M	-2.31M	-2.19M	-2.39M	-2.74M	-2.98M	-4.1M	-4.22M	-3.86M	-5.73M	-9.24M	-9.91M	-9.76M	-12.43M
Depreciation & Amortization	0	0	0	0	0	0	0	0	0	0	0	0	0	0	965.01K	0	838.95K	834.22K	820.18K	805.25K
Stock-Based Compensation	195.74K	0	111.13K	33.28K	13.99K	379.14K	50.54K	53.3K	62.6K	79.42K	143.37K	175.04K	0	0	717.17K	0	0	1.63M	1.47M	1.47M
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Non-Cash Items	413.43K	178.42K	0	0	0	0	0	0	0	0	-62.94K	-260.28K	-6.12M	-2.13M	0	2.73M	1.5M	0	0	0
Working Capital Changes	-2.5M	1.6M	-308.03K	-770.49K	2.12M	-1.43M	-916.05K	3.45M	-1.44M	-1.52M	292.11K	1.94M	3.17M	466.74K	-4.13M	-4.65M	6.11M	-4.78M	2.62M	3.64M
Change in Receivables	0	-7.9K	295.75K	9.18K	784.43K	-112.06K	-1.6M	1.75M	-638.68K	-823.65K	-944.5K	1.66M	336.79K	319.12K	-720.99K	-1.05M	-625.44K	-1.95K	6	43
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Payables	-1.5M	614.3K	-365.26K	-603.22K	177.8K	336.11K	-803.38K	877.66K	-270.03K	204.51K	402.91K	-356.6K	447.05K	111.17K	0	3.97M	-301.06K	-3.95M	1.4M	3.65M
Cash from Investing	0	0	0	0	0	0	0	0	0	0	0	0	18.78M	-112.61K	-127.34K	-99.37K	-2.27M	-2.45M	-349.84K	-2M
Capital Expenditures	0	0	0	0	0	0	0	0	0	0	0	0	112.61K	0	-127.34K	4.72M	-2.27M	-2.45M	-349.84K	-2M
CapEx % of Revenue	-	-	-	0%	0%	0%	0%	0%	-	0%	0%	-	14.77%	0%	16.77%	472.05%	286.68%	254.29%	28.17%	-
Acquisitions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	0	0	0	0	0	0	0	0	0	18.66M	-112.61K	0	-4.82M	0	0	0	0
Cash from Financing	0	0	0	9.86M	100	505	14.9M	1.7K	44.61K	49.1K	5.13K	479.27K	736	619.97K	138.56K	0	63.57K	0	0	0
Debt Issued (Net)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Equity Issued (Net)	0	0	0	9.86M	100	505	14.89M	1.7K	36.9K	49.1K	5.13K	394.67K	736	619.97K	138.56K	0	63.57K	0	0	0
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Financing	0	0	0	0	0	0	3.66K	0	7.7K	0	0	84.61K	0	0	0	0	0	0	0	0
Net Change in Cash	-3.72M	-1.4M	-1.9M	7.13M	-1.88M	-5.5M	10.19M	1.2M	-3.52M	-3.79M	-2.36M	-648.19K	11.72M	-5.38M	-6.29M	-7.75M	-3M	-14.68M	-5.21M	-8.52M
Free Cash Flow	-3.72M	-1.4M	-1.9M	-2.74M	-1.88M	-5.5M	-4.7M	1.2M	-3.57M	-3.84M	-2.37M	-1.13M	-6.94M	-5.89M	-6.43M	-2.93M	-3.06M	-14.68M	-5.21M	-8.52M
FCF Margin %	-	-	-	-221.9%	-218.11%	-1575.39%	-208.86%	62.18%	-305.12%	-308.44%	-224.09%	-437.67%	-910.5%	-477.04%	-847.37%	-292.88%	-387.21%	-1522.13%	-419.42%	-
FCF Growth %	-97.85%	74.47%	59.6%	-328.47%	47.35%	-43.33%	-98.65%	206.21%	48.62%	34.83%	63.2%	61.49%	-126.86%	59.88%	-23.52%	65.62%	57.78%	-55.54%	45.77%	-15.81%
FCF per Share	-0.19	-0.07	-0.12	-0.16	-0.13	-0.50	-0.52	0.13	-0.40	-0.43	-0.27	-0.13	-0.79	-0.68	-0.77	-0.35	-0.37	-1.77	-0.63	-1.03
FCF Conversion (FCF/Net Income)	2.03x	0.44x	1.12x	1.37x	0.47x	1.24x	1.23x	-0.52x	1.63x	1.60x	0.84x	0.38x	-2.80x	1.19x	1.64x	1.10x	0.09x	1.23x	0.50x	0.52x
Interest Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0